Uniplan Investment Counsel’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Uniplan Investment Counsel's LMAT Position: Q1 2026 in Review
Uniplan Investment Counsel opened a new position in LeMaitre Vascular (LMAT) in Q1 2026: 451 shares worth $49.3K. The stake represents 0.01% of the portfolio and ranks #154 among its holdings. This is a return to the name: Uniplan Investment Counsel previously reported a position in LMAT as recently as Q3 2020.
Uniplan Investment Counsel first reported a position in LMAT in Q2 2015 and has held it in 6 quarters since. The position peaked at $5.71M in Q2 2015. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Uniplan Investment Counsel held 451 shares of LeMaitre Vascular worth $49.3K as of Q1 2026.
- LeMaitre Vascular was a new Uniplan Investment Counsel position in Q1 2026.
- LeMaitre Vascular made up 0.01% of Uniplan Investment Counsel's portfolio in Q1 2026, its #154 holding.
- Uniplan Investment Counsel first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 6 quarters since.
- Uniplan Investment Counsel's LeMaitre Vascular position peaked at $5.71M in Q2 2015.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.